Gao, Ying
Chang, Sanshuai
Du, Xin
Dong, Jianzeng
Xu, Xiaoli
Zhou, Yingchun
Lip, Gregory Y. H.
Ma, Changsheng
Funding for this research was provided by:
Ministry of science and Technology of the People’s Republic of China (2013BAI09B02)
Article History
First Online: 11 May 2019
Compliance with Ethical Standards
:
: This study complied with standards required for observational study. Ethical approval was obtained from the Human Research Ethics Committees at Beijing Anzhen Hospital. Ethics review boards in each participating hospital approved their participation. Each patient provided informed consent for long-term follow-up.
: This study was supported by a Grant (2013BAI09B02) from the Ministry of Science and Technology of the People’s Republic of China and Grants (ZYLX201302, D111100003011004, and D131100002313001) from the Beijing Municipal Commission of Science and Technology.
: C.-S.M. has received honoraria from Bristol-Myers Squibb (BMS), Pfizer, Johnson & Johnson, Boehringer-Ingelheim (BI) and Bayer for giving lectures. J.-Z.D. has also received honoraria from Johnson & Johnson for giving lectures. G.Y.H.L. is or has been a consultant for Bayer/Janssen, BMS/Pfizer, Medtronic, BI, Novartis, Verseon, and Daiichi-Sankyo and a speaker for Bayer, BMS/Pfizer, Medtronic, BI, and Daiichi-Sankyo. YG, SC, XD, XX, and YZ have no conflicts of interest that are directly relevant to the content of this article.